KENS 5: San Antonio researchers developing brain injury treatment
October 19, 2021
Dr. James Lechleiter, Cell Systems and Anatomy, is quoted in this KENS 5 story. Watch story
Texas Public Radio: Texas’ new Alzheimer’s research center zeroes in on the disease’s disproportionate impact on Latinos
October 14, 2021
Dr. Sudha Seshadri, Neurology, Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was a guest on Texas Public Radio’s “The Source” and discussed how UT Health San Antonio and The University of Texas Rio Grande Valley will work together to address the disproportionate impact of Alzheimer’s in Latinos at a new nationally designated Alzheimer’s Disease […]
Brain injury therapy advancing toward human studies
October 8, 2021
Research that began at The University of Texas Health Science Center at San Antonio 15 years ago is nearing a significant milestone: human testing of an intravenous (IV) drug to treat brain injuries such as concussion and stroke.
Fox 29: Dementia Friendly San Antonio
October 5, 2021
San Antonio earned the national designation of “Dementia Friendly City” by having a community grassroots effort working to welcome and support those with the condition, and provide helpful resources to caregivers. The Oct. 4 presentation took place at the UT Health San Antonio School of Nursing, whose Caring for the Caregiver program collaborates with the […]
‘Dementia Friendly City’ proclamation urges inclusion, support
October 5, 2021
San Antonio was the third Texas city to earn the designation “Dementia Friendly City” by having a community grassroots effort working to welcome and support those with the condition, and provide helpful resources to caregivers. The designation is from the national nonprofit support organization Dementia Friendly America.
Brain injury therapy advancing toward human studies
October 4, 2021
UT Health Science Center San Antonio spinoff company gains funding for trial in people. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Oct. 4, 2021) — Research that began at The University of Texas Health Science Center at San Antonio 15 years ago is nearing a significant milestone: human testing of an intravenous (IV) drug […]